61 research outputs found
Dual properties of the relative belief of singletons
In this paper we prove that a recent Bayesian approximation of belief functions, the relative belief of singletons, meets a number of properties with respect to Dempster’s rule of combination which mirrors those satisfied by the relative plausibility of singletons. In particular, its operator commutes with Dempster’s sum of plausibility functions, while perfectly representing a plausibility function when combined through Dempster’s rule. This suggests a classification of all Bayesian approximations into two families according to the operator they relate to
NMR-Based Prostate Cancer Metabolomics
Author's accepted version (postprint).This is an Accepted Manuscript of an article published by Springer in Methods in Molecular Biology on 22 May 2018.Available online: https://doi.org/10.1007/978-1-4939-7845-8_14acceptedVersio
Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
<p>Abstract</p> <p>Background</p> <p>Today's clinical diagnostic tools are insufficient for giving accurate prognosis to breast cancer patients. The aim of our study was to examine the tumor metabolic changes in patients with locally advanced breast cancer caused by neoadjuvant chemotherapy (NAC), relating these changes to clinical treatment response and long-term survival.</p> <p>Methods</p> <p>Patients (n = 89) participating in a randomized open-label multicenter study were allocated to receive either NAC as epirubicin or paclitaxel monotherapy. Biopsies were excised pre- and post-treatment, and analyzed by high resolution magic angle spinning magnetic resonance spectroscopy (HR MAS MRS). The metabolite profiles were examined by paired and unpaired multivariate methods and findings of important metabolites were confirmed by spectral integration of the metabolite peaks.</p> <p>Results</p> <p>All patients had a significant metabolic response to NAC, and pre- and post-treatment spectra could be discriminated with 87.9%/68.9% classification accuracy by paired/unpaired partial least squares discriminant analysis (PLS-DA) (<it>p </it>< 0.001). Similar metabolic responses were observed for the two chemotherapeutic agents. The metabolic responses were related to patient outcome. Non-survivors (< 5 years) had increased tumor levels of lactate (<it>p </it>= 0.004) after treatment, while survivors (≥ 5 years) experienced a decrease in the levels of glycine (<it>p </it>= 0.047) and choline-containing compounds (<it>p </it>≤ 0.013) and an increase in glucose (<it>p </it>= 0.002) levels. The metabolic responses were not related to clinical treatment response.</p> <p>Conclusions</p> <p>The differences in tumor metabolic response to NAC were associated with breast cancer survival, but not to clinical response. Monitoring metabolic responses to NAC by HR MAS MRS may provide information about tumor biology related to individual prognosis.</p
Agile software development – Do we really calculate the costs? A multivocal literature review
Agile software development methods, in their various different forms, have become the basis for most software projects in today’s world. The methodology is present in almost all organisations today. However, despite the popularity, failure rates in software projects remain high. This paper identifies why agile methodologies have become so successful. In addition, the paper discusses certain factors that may often be overlooked in organisations that have adopted agile methods, such as rework, maintainability, adoption, turnover rates and the potential costs associated with each. The research carried out was a multivocal literature review (MLR). Multiple white and grey literature which was deemed to be relevant was selected. 32 contributions from white literature were selected for use in the review as well as 8 from grey literature sources. We find that while agile has many advantages, organisations may overlook the potential downsides of using an agile methodology. If not managed or implemented correctly, organisations risk taking on more hidden and expensive costs, for example in relation to rework. It is important that organisations are sufficiently trained in agile methods in order to succeed
Targeting cancer metabolism: a therapeutic window opens
Genetic events in cancer activate signalling pathways that alter cell metabolism. Clinical evidence has linked cell metabolism with cancer outcomes. Together, these observations have raised interest in targeting metabolic enzymes for cancer therapy, but they have also raised concerns that these therapies would have unacceptable effects on normal cells. However, some of the first cancer therapies that were developed target the specific metabolic needs of cancer cells and remain effective agents in the clinic today. Research into how changes in cell metabolism promote tumour growth has accelerated in recent years. This has refocused efforts to target metabolic dependencies of cancer cells as a selective anticancer strategy.Burroughs Wellcome FundSmith Family FoundationStarr Cancer ConsortiumDamon Runyon Cancer Research FoundationNational Institutes of Health (U.S.
Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes
A case study in agility and evolving the long-lived software system
Understanding how to effectively evolve long-lived software systems is of ongoing interest. Agile development methods are regarded as best practice by industry for software teams, and empiricists regard studying long-lived agile projects and Scrum teams as priorities. In this paper we explore, through empirical study, and with consideration to organisational context, a case study of a successful, long-lived software project team, implementing Scrum techniques. We apply both qualitative and quantitative analysis, incorporating a questionnaire of 24 professionals and project source code repository analysis. Survey respondents felt, in general, that agile led to desirable project outcomes and fostered effective communication. However, some specific cautions were identified. Diverse process, toolset and software were used to meet project needs. Evolutionary themes observed in the system source code repository included language type fragmentation and growing support for the web stack. Continued codebase growth was measured after a transition to Scrum. Three frontiers for future innovation were discovered: to explore development toolsets with integration as an agile enabler, automating agile and business process interfaces and, strategic evolution of language fragmented architectures, in the agile context.Shannon Fehlmann, Katrina Falkne
SFRP4 gene expression is increased in aggressive prostate cancer
Abstract Increased knowledge of the molecular differences between indolent and aggressive prostate cancer is needed for improved risk stratification and treatment selection. Secreted frizzled-related protein 4 (SFRP4) is a modulator of the cancer-associated Wnt pathway, and previously suggested as a potential marker for prostate cancer aggressiveness. In this study, we investigated and validated the association between SFRP4 gene expression and aggressiveness in nine independent cohorts (n = 2157). By differential expression and combined meta-analysis of all cohorts, we detected significantly higher SFRP4 expression in cancer compared with normal samples, and in high (3–5) compared with low (1–2) Grade Group samples. SFRP4 expression was a significant predictor of biochemical recurrence in six of seven cohorts and in the overall analysis, and was a significant predictor of metastatic event in one cohort. In our study cohort, where metabolic information was available, SFRP4 expression correlated significantly with the concentrations of citrate and spermine, two previously suggested biomarkers for aggressive prostate cancer. SFRP4 immunohistochemistry in an independent cohort (n = 33) was not associated with aggressiveness. To conclude, high SFRP4 gene expression is associated with high Grade Group and recurrent prostate cancer after surgery. Future studies investigating the mechanistic and clinical usefulness of SFRP4 in prostate cancer are warranted
- …